Erratum: Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger (Journal of Pathology (2006) DOI: 10.1002/path.2075);Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger

Journal of Pathology

Volumn 211, Issue 1, 2007, Pages 18-25

  Wild, P J ^a   Giedl, J ^b   Stoehr, R ^b   Junker, K ^c   Boehm, S ^b   van Oers, J M M ^d   Zwarthoff, E C ^d   Blaszyk, H ^e   Fine, S W ^f   Humphrey, P A ^g   Dehner, L P ^g   Epstein, J I ^h   Hartmann, A ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g BARNES JEWISH HOSPITAL   (United States)

^h EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Adolescent; Bladder; Child; Genomic characterization; Neoplasia

Indexed keywords

CYTOKERATIN 20; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GENOMIC DNA; KI 67 ANTIGEN; MITOMYCIN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53;

ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CHILDHOOD CANCER; CHROMOSOME 17P; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; PAPILLOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENT CANCER; SCHOOL CHILD; TREATMENT FAILURE; UROGENITAL TRACT TUMOR; WART VIRUS;

EID: 33846226558     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3973     Document Type: Erratum

References (38)

1. Migaldi M, Rossi G, Maiorana A, Sartori G, Ferrari P, De Gaetani C, et al. Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study. BJU Int 2004;94:311-316.
2. Benson RC Jr, Tomera KM, Kelalis PP. Transitional cell carcinoma of the bladder in children and adolescents. J Urol 1983;130:54-55.
3. McGuire EJ, Weiss RM, Baskin AM. Neoplasms of transitional cell origin in first twenty years of life. Urology 1973;1:57-59.
4. McCarthy JP, Gavrell GJ, LeBlanc GA. Transitional cell carcinoma of bladder in patients under thirty years of age. Urology 1979;13:487-489.
5. Javadpour N, Mostofi FK. Primary epithelial tumors of the bladder in the first two decades of life. J Urol 1969;101:706-710.
6. Hoenig DM, McRae S, Chen SC, Diamond DA, Rabinowitz R, Caldamone AA. Transitional cell carcinoma of the bladder in the pediatric patient. J Urol 1996;156:203-205.
7. Paduano L, Chiella E. Primary epithelial tumors of the bladder in children. J Urol 1988;139:794-795.
8. Yossepowitch O, Dalbagni G. Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. J Urol 2002;168:61-66.
9. Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification. J Urol 2005;174:1976-1980.
10. Sauter G, Algaba F, Amin MB, Busch C, Cheville J, Gasser T, et al. Non-invasive urothelial tumours. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, Eble JN, Sauter G, Epstein JI, Sesterhenn I (eds). IARC Press: Lyon, 2004; 110-123.
11. Wild P, Knuechel R, Dietmaier W, Hofstaedter F, Hartmann A. Laser microdissection and microsatellite analyses of breast cancer reveal a high degree of tumor heterogeneity. Pathobiology 2000;68:180-190.
12. Dietmaier W, Hartmann A, Wallinger S, Heinmoller E, Kerner T, Endl E, et al. Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Pathol 1999;154-83-95.
13. Hartmann A, Rosner U, Schlake G, Dietmaier W, Zaak D, Hofstaedter F, et al. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis. Lab Invest 2000;80:709-718.
14. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257.
15. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997;57:4749-4756.
16. Schlegel J, Bocker T, Zirngibl H, Hofstadter F, Ruschoff J. Detection of microsatellite instability in human colorectal carcinomas using a non-radioactive PCR-based screening technique. Virchows Arch 1995;426:223-227.
17. Hartmann A, Zanardo L, Bocker-Edmonston T, Blaszyk H, Dietmaier W, Stoehr R, et al. Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res 2002;62:6796-6802.
18. Klopocki E, Kristiansen G, Wild PJ, Klaman I, Castanos-Velez E, Singer G, et al. Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol 2004;25:641-649.
19. Harnden P, Mahmood N, Southgate J. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet 1999;353:974-977.
20. van Oers JM, Lurkin I, van Exsel AJ, Nijsen Y, van Rhijn BW, van der Aa MN, et al. A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine. Clin Cancer Res 2005;11:7743-7748.
21. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992;13:718-725.
22. Stockfleth E, Meinke B, Arndt R, Christophers E, Meyer T. Identification of DNA sequences of both genital and cutaneous HPV types in a small number of keratoacanthomas of nonimmunosuppressed patients, Dermatology 1999;198:122-125.
23. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995;33:690-695.
24. Billerey C, Chopin D, Aubriot-Lorton MH, Ricol D, Gil Diez de Medina S, Van Rhijn B, et al. Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol 2001;158:1955-1959.
25. Sibley K, Stern P, Knowles MA. Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours. Oncogene 2001;20:4416-4418.
26. van Rhijn BW, Lurkin I, Radvanyi F, Kirkels WJ, van der Kwast TH, Zwarthoff EC. The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res 2001;61:1265-1269.
27. van Rhijn BW, Montironi R, Zwarthoff EC, Jobsis AC, van der Kwast TH. Frequent FGFR3 mutations in urothelial papilloma. J Pathol 2002;198:245-251.
28. Richter J, Jiang F, Gorog JP, Sartorius G, Egenter C, Gasser TC, et al. Marked genetic differences between stage pTa and stage pTI papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 1997;57:2860-2864.
29. Simon R, Burger H, Brinkschmidt C, Bocker W, Hertle L, Terpe HJ. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 1998;185:345-351.
30. Takahashi T, Habuchi T, Kakehi Y, Mitsumori K, Akao T, Terachi T, et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res 1998;58:5835-5841.
31. Zhao J, Richter J, Wagner U, Roth B, Schramal P, Zellweger T, et al. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). CancerRes 1999;59:4658-4661.
32. Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM. Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer. Int J Cancer 1995;64:99-103.
33. Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 1999;154:721-727.
34. Steidl C, Simon R, Burger H, Brinkschmidt C, Hertle L, Bocker W, et al. Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium. J Pathol 2002;198:115-120.
35. Christensen M, Jensen MA, Wolf H, Orntoft TF. Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer. Int J Cancer 1998;79:396-401.
36. Knowles MA. Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder. Urol Res 1992;20:297-301.
37. Mincione GP, Messerini L, Saltutti C, Di Cello V, Dominici A, Giannelli E, et al. HPV and p53 in urinary bladder carcinoma. Pathologica 1994;86:244-246.
38. Linn JF, Sesterhenn I, Mostofi FK, Schoenberg M. The molecular characteristics of bladder cancer in young patients. J Urol 1998:159:1493-1496.